Practice Economics

Number of malpractice payments down 28% since 2004


 

References

The annual number of medical malpractice payment reports fell 28% from 2004 to 2014, according to the Agency for Healthcare Research and Quality.

The total number of medical malpractice payment reports (MMPRs) for 2014 was 12,699, a decrease of 28% since 2004, when there were 17,641. The total had gone down every year until a slight increase in 2013, but the number held steady in 2014, the AHRQ reported in the Chartbook on Patient Safety.

Since 2004, MMPRs related to inpatient settings have been dropping slightly faster than outpatient-related MMPRs, with the exception, again, of 2013, when the number of inpatient MMPRs went up while the outpatient total dropped. Both types went up in 2014, but the category of “other” – reports related to unknown settings and those from a combination of the two – dropped in 2014 to keep the overall number from going up again, data from the National Practitioner Data Bank show.

Looking at the types of allegation leading to MMPRs, treatment was highest, accounting for 27.4% of the total from 2004 to 2014, with diagnosis right behind at 27.1%, followed by surgery at 23.5% and obstetrics at 6.7%. Medication-related cases represented 5.3% of all MMPRs over that period, the AHRQ noted.

rfranki@frontlinemedcom.com

Recommended Reading

ABIM to test open-book MOC assessments
MDedge Hematology and Oncology
10 ways EHRs lead to burnout
MDedge Hematology and Oncology
VIDEO: Determining your practice’s fair market value in a quality-based world
MDedge Hematology and Oncology
What are the best, worst states for physicians?
MDedge Hematology and Oncology
What are the best, worst states for physicians?
MDedge Hematology and Oncology
State board discipline of physicians varies widely by state
MDedge Hematology and Oncology
EHR Report: Take your medicine!
MDedge Hematology and Oncology
Could value-based care raise False Claims Act liability?
MDedge Hematology and Oncology
SURVEY: Telemedicine high priority, but reimbursement remains challenging
MDedge Hematology and Oncology
Medicare Part B drug payment proposal could cost some doctors
MDedge Hematology and Oncology